|
|
Volumn 89, Issue 2, 2002, Pages 226-229
|
|
Dose response, safety, and efficacy of an extended-release formulation of lovastatin in adults with hypercholesterolemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
LOW DENSITY LIPOPROTEIN;
MEVINOLIN;
TRIACYLGLYCEROL;
ADULT;
AGED;
ARTICLE;
BLOOD ANALYSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DOUBLE BLIND PROCEDURE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERANCE;
HUMAN;
HYPERCHOLESTEROLEMIA;
INCIDENCE;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
MYALGIA;
MYOSITIS;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REGRESSION ANALYSIS;
RISK FACTOR;
TREATMENT OUTCOME;
URINALYSIS;
ADULT;
AGED;
ANTICHOLESTEREMIC AGENTS;
DELAYED-ACTION PREPARATIONS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
HYPERCHOLESTEROLEMIA;
LOVASTATIN;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
|
EID: 0037081627
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(01)02207-X Document Type: Article |
|
Times cited : (5)
|
|
References (7)
|
